Vicapsys Life Sciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VICP research report →
Price Chart
About the company
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses.
- CEO
- Federico Pier
- IPO
- 1998
- Employees
- 2
- HQ
- Suwanee, GA, US
Get TickerSpark's AI analysis on VICP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $46.94M
- P/E
- -179.01
- PEG
- -4.23
- P/S
- 0.00
- P/B
- -14.45
- EV/EBITDA
- -176.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 8.65%
- ROIC
- 9.21%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-651,803
- Net Income
- $-689,887+30.3%
- EPS
- $-0.02+32.3%
- OCF Growth
- +82.4%
- FCF Growth
- +82.4%
- 52W High
- $1.77
- 52W Low
- $0.15
- 50D MA
- $1.46
- 200D MA
- $1.46
- Beta
- -4.13
- RSI (14)
- 18
- Avg Volume
- 7
No earnings-call transcripts are available for VICP yet.
- Free Float
- 56.9%
- Shares Outstanding
- 32.37M
- Float Shares
- 18.41M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 20, 20 | Wildcat Capital Management, LLC | other | 0 |
| Sep 3, 10 | YURKOWSKI MICHAEL | sell | 5,000 |
| Aug 9, 10 | YURKOWSKI MICHAEL | sell | 20,000 |
| May 13, 10 | MOORE BOBBY M JR | other | 0 |
| Jan 26, 10 | YURKOWSKI MICHAEL | other | 5,000 |
| Jan 14, 10 | YURKOWSKI MICHAEL | sell | 5,000 |
| Nov 18, 09 | REES RODGER | other | 50,000 |
| Dec 8, 09 | SEDDON RYAN | other | 0 |
| Jun 30, 09 | SEDDON RYAN | other | 500,000 |
| Dec 8, 09 | PIER FEDERICO | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VICP coverage
Recent articles, reports, and earnings notes.
No research on VICP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VICP report →